The following table includes
certain tax information for all Target Maturity
Date Junk Bond ETFs listed on U.S. exchanges that are currently tracked
by ETF Database, including applicable short - term and long - term
capital gains rates and the tax form on which gains or losses in each ETF will be reported.
In assessing the adequacy of the offer presented
by MediciNova, the Board of Avigen also obtained an opinion,
dated March 17, 2009, from RBC
Capital Markets Corporation («RBC»), that, as of the
date of such opinion, and subject to
certain assumptions, qualifications and other considerations set forth in its written opinion, the consideration being offered
by MediciNova in its proposal to acquire Avigen is inadequate, from a financial point of view, to the stockholders of Avigen.